Fig. 4From: Differences in anticoagulation strategy and outcome in atrial fibrillation patients with chronic kidney disease: a CODE-AF registry studyDosage of non-vitamin K oral anticoagulants in patients without and with renal dose reduction indication. a Overall, b dabigatran, c rivaroxaban, and d apixabanBack to article page